Editas Medicine, Inc. (EDIT)
2.76
+0.02
(+0.73%)
USD |
NASDAQ |
Apr 08, 16:00
2.77
+0.01
(+0.36%)
After-Hours: 20:00
Editas Medicine EPS Diluted (Quarterly) : -0.0578 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 0.5326 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.62M |
| Revenue (Quarterly) | 24.74M |
| Total Expenses (Quarterly) | 30.36M |
| Enterprise Value | 200.19M |
| Gross Profit Margin (Quarterly) | 96.75% |
| Profit Margin (Quarterly) | -22.72% |
| Earnings Yield | -67.38% |
| Normalized Earnings Yield | -48.93 |